The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Abstract
Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies can estimate the extent of CMV “obsession” by identifying antigen-specific cells using peptide-MHC class-I or class-II multimers (Altman et al. 1996; Davis et al. 2011).”
From Is immunosenescence influenced by our lifetime “dose” of exercise? (2016) · cites this paper as Altman et al. 1996
Citations
Cites
Handbook of Experimental Immunology.
Denman, A. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1376_1 · Cited by 2,414
HANDBOOK OF EXPERIMENTAL IMMUNOLOGY
Holborow, E. J. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.4.534-c · Cited by 678
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 671
Schatz, P. J. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1138 · Cited by 585
Antigen-Specific Development of Primary and Memory T Cells in Vivo
McHeyzer‐Williams, M. G., & Davis, M. M. (1995) · Science · doi:10.1126/science.7535476 · Cited by 439
Self-citationKo, H. S., Fu, S. M., WINCHESTER, R. J., Yu, D. T. Y., & Kunkel, H. G. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.150.2.246 · Cited by 439
Nixon, D. F., Townsend, A., Elvin, J. G., Rizza, C. R., Gallwey, J., & McMichael, A. J. (1988) · Nature · doi:10.1038/336484a0 · Cited by 431
Self-citationMatsui, K., Boniface, J. J., Steffner, P., Reay, P. A., & Davis, M. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12862 · Cited by 425
Self-citationCarmichael, A. J., Jin, X., Sissons, P., & Borysiewicz, L. K. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.249 · Cited by 418
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
Hoffenbach, A., Langlade‐Demoyen, P., Dadaglio, G., VILMER, E., Michel, F., Mayaud, C. M., Autran, B., & Plata, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.452 · Cited by 304
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Hayakawa K., Ishii R., Yamasaki K., Kishimoto T., Hardy R. R., ibid. 84, 1379 (1987);
- Schatz P. J., Biotechnology 11, 1138 (1993).
- Johnson R. P., et al., ibid. 147, 1512 (1991).
- Koup R. A., et al., ibid. 174, 1593 (1991).
- Tripp R. A., Hou S., Doherty P. C., ibid. 154, 5870 (1995);
Cited by
Sorted by citations
Items 601–700 of 1,007
H2-M3–Restricted T Cells in Bacterial Infection
Kerksiek, K. M., Busch, D. H., Pilip, I. M., Allen, S. E., & Pamer, E. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.195 · Cited by 125
“We PCR mutagenized H2-M3 to remove the leader, transmembrane, and cytosolic regions and to add a COOH-terminal biotinylation site (31, 32), but expression of this construct in E.”
BackgroundGoulder, P., Tang, Y., Brander, C., Betts, M. R., Altfeld, M. A., Annamalai, K., Piechocka‐Trocha, A., He, S., Rosenberg, E. S., Ogg, G. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1819 · Cited by 125
Self-citationInterrogating the repertoire: broadening the scope of peptide–MHC multimer analysis
Davis, M. M., Altman, J. D., & Newell, E. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3020 · Cited by 124
Self-citationIrving, M. B., Zoete, V., Hebeisen, M., Schmid, D. A., Baumgärtner, P., Guillaume, P., Romero, P. J., Speiser, D. E., Luescher, I. F., Rufer, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357673 · Cited by 124
“BiotinylatedA2/NYESO157–165 was prepared as previously described (25).”
Marktel, S., Magnani, Z. I., Ciceri, F., Cazzaniga, S., Riddell, S. R., Traversari, C., Bordignon, C., & Bonini, C. (2003) · Blood · doi:10.1182/blood-2002-08-2351 · Cited by 124
Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen
Coulie, P. G., Karanikas, V., Lurquin, C., Colau, D., Connerotte, T., Hanagiri, T., Pel, A. V., Lucas, S., Godelaine, D., Lonchay, C., et al. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18804.x · Cited by 124
Singh‐Jasuja, H., Emmerich, N., & Rammensee, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0480-x · Cited by 124
“The most accurate method to determine the frequency of CD8 T cells ex vivo is using soluble fluorescent tetrameric HLA-peptide complexes commonly known as tetramers [1].”
The role of EBV in post-transplant malignancies: a review
Hopwood, P. A., & Crawford, D. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.4.248 · Cited by 123
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Höllsberg, P. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.308-333.1999 · Cited by 123
“Recent advances in generating MHC-peptide complexes and peptide-loaded soluble MHC class I-immunoglobulin complexes make it feasible to directly isolate antigen-specific T cells (11, 101).”
BackgroundRowland‐Jones, S., Tan, R., & McMichael, A. J. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60745-2 · Cited by 123
Self-citationGamadia, L. E., van Leeuwen, E. M. M., Remmerswaal, E. B. M., Yong, S.-L., Surachno, S., Wertheim-van Dillen, P. M. E., ten Berge, I. J. M., & van Lier, R. A. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6107 · Cited by 122
Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
Tan, R., Xu, X., Ogg, G. S., Hansasuta, P., Dong, T., Rostron, T., Luzzi, G. A., Conlon, C. P., Screaton, G. R., McMichael, A. J., et al. (1999) · Blood · doi:10.1182/blood.v93.5.1506 · Cited by 122
Self-citationBarouch, D. H., McKay, P. F., Sumida, S. M., Santra, S., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Chakrabarti, B. K., Xu, L., Nabel, G. J., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8729-8735.2003 · Cited by 122
Self-citationO'Callaghan, C. A., Byford, M. F., Wyer, J. R., Willcox, B. E., Jakobsen, B. K., McMichael, A. J., & Bell, J. I. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.2930 · Cited by 122
Self-citationIdenoue, S., Hirohashi, Y., Torigoe, T., Sato, Y., Tamura, Y., Hariu, H., Yamamoto, M., Kurotaki, T., Tsuruma, T., Asanuma, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0817 · Cited by 122
“To confirm this point, we first studied the CTLp frequency in several survivin-positive cancer patients’ PBMCs by using HLAA24/survivin-2B80-88 peptide tetramer as described previously (31).”
MethodRecognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes
Boon, A. C. M., de Mutsert, G., van Baarle, D., Smith, D. J., Lapedes, A. S., Fouchier, R. A. M., Sintnicolaas, K., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2453 · Cited by 122
“virus (NPESV, NPDSI, NPDTI, NPDPI) as previously described (20).”
BackgroundKuon, W., Holzhütter, H., Appel, H., Grolms, M., Kollnberger, S., Traeder, A., Henklein, P., Weiss, E. H., Thiel, A., Lauster, R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4738 · Cited by 122
“Wiley, Boston University, Boston, MA) was modified by tagging with the BirA recognition sequence as previously described (33) and by mutating the Cys(67) to Ser(67) (34).”
MethodJames, E., Chai, J., Dewchand, H., Macchiarulo, E., Dazzi, F., & Simpson, E. (2003) · Blood · doi:10.1182/blood-2002-10-3170 · Cited by 121
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection
Richter, K., Agnellini, P., & Oxenius, A. (2009) · International Immunology · doi:10.1093/intimm/dxp107 · Cited by 121
Chang, J., Srikiatkhachorn, A., & Braciale, T. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4254 · Cited by 121
“MHC class I-peptide tetramers were produced as described previously (15).”
MethodAyyoub, M., Stevanović, S., Şahin, U., Guillaume, P., Servis, C., Rimoldi, D., Valmori, D., Romero, P. J., Cerottini, J., Rammensee, H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1717 · Cited by 121
“A2/SSX-241–49 multimeric complexes were synthesized as described (23).”
MethodT-cell clonality in immune responses
Maini, M. K., Casorati, G., Dellabona, P., Wack, A., & Beverley, P. C. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01472-3 · Cited by 121
Sprent, J. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80084-2 · Cited by 120
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire
Ho, W., Nguyen, H., Wölfl, M., Kuball, J. H. E., & Greenberg, P. D. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.11.023 · Cited by 120
“HLA-A⁎0201/peptide tetramers were generated as previously described (Altman et al., 1996) using streptavidin-PE (Molecular Probes, Eugene, OR).”
MethodKwok, W. W., Tan, V., Gillette, L., Littell, C. T., Soltis, M. A., LaFond, R. E., Yang, J., James, E. A., & DeLong, J. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102190 · Cited by 120
“The development of MHC-tetramer reagents provided an additional tool capable of detecting Ag-specific T cells in a direct fashion (5, 6).”
MethodBertoletti, A., & Maini, M. K. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00108-4 · Cited by 120
Estcourt, M. J., Ramsay, A. J., Brööks, A. G., Thomson, S. A., Medveckzy, C. J., & Ramshaw, I. A. (2002) · International Immunology · doi:10.1093/intimm/14.1.31 · Cited by 120
Kwok, W. W., Liu, A. W., Novak, E. J., Gebe, J. A., Ettinger, R. A., Nepom, G. T., Reymond, S. N., & Koelle, D. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4244 · Cited by 120
β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure
Skowera, A., Ladell, K., McLaren, J. E., Dolton, G. M., Matthews, K. K., Emma Gostick, D., Kronenberg‐Versteeg, D., Eichmann, M., Knight, R. R., Heck, S., et al. (2014) · Diabetes · doi:10.2337/db14-0332 · Cited by 118
“In particular, antigen-specific CD8 T cells can now be enumerated routinely by flow cytometry irrespective of functional outputs due to the advent of recombinant peptide-HLAI (pHLAI) proteins in various fluorochrome-tagged multimeric formats (10-13).”
BackgroundImpact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
Maecker, H. T., Moon, J., Bhatia, S., Ghanekar, S., Maino, V. C., Payne, J. K., Kuus-Reichel, K., Chang, J. C. C., Summers, A. N., Clay, T. M., et al. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-17 · Cited by 119
“These are increasingly being replaced by single-cell assays, such as MHC-peptide tetramer staining [20], cytokine flow cytometry (CFC) – also known as intracellular cytokine staining (ICS) [21,22], and enzymelinked immunospot (ELISPOT) [23].”
Karanikas, V., Colau, D., Baurain, J., Chiari, R., Thonnard, J., Gutierrez-Roelens, I., Goffinet, C., SCHAFTINGEN, E. V., Weynants, P., Boon, T., et al. (2001) · PubMed · Cited by 119
Vescovini, R., Telera, A. R., Fagnoni, F. F., Biasini, C., Medici, M. C., Valcavi, P., Pede, P. D., Lucchini, G., Zanlari, L., Passeri, G., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.004 · Cited by 120
Trimble, L. A., Shankar, P., Patterson, M. N., Daily, J. P., & Lieberman, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7320-7330.2000 · Cited by 119
“As many as 1 in 100 circulating CD8 T cells are specific for a single HIV peptide epitope in untreated patients (1, 37).”
InfluentialMasopust, D., Murali-Krishna, K., & Ahmed, R. (2007) · Journal of Virology · doi:10.1128/jvi.01459-06 · Cited by 114
“LCMV-specific CD8 T cells were detected using H-2D tetramers (NP396, GP33, and GP276) and H-2K (GP34) tetramers, constructed as previously described (3).”
Li, J., Liu, H., Xr, Z., Xu, J.-P., Hu, W.-K., Liang, M., Chen, S.-Y., Hu, F., & Chu, D.-T. (2008) · Gene Therapy · doi:10.1038/gt.2008.179 · Cited by 118
Bim mediates apoptosis of CD127lo effector T cells and limits T cell memory
Wojciechowski, S., Jordan, M. B., Zhu, Y., White, J., Zajac, A. J., & Hildeman, D. A. (2006) · European Journal of Immunology · doi:10.1002/eji.200635897 · Cited by 120
Yajima, T., Nishimura, H., Ishimitsu, R., Watase, T., Busch, D. H., Pamer, E. G., Kuwano, H., & Yoshikai, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1198 · Cited by 116
“MHC-peptide tetramers for staining of epitope-specific cells were generated as recently described (27, 28).”
MethodFailing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue
van Baarle, D., Kostense, S., van Oers, M. H. J., Hamann, D., & Miedema, F. F. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02326-8 · Cited by 118
Abel, M., Sène, D., Pol, S., Bourlière, M., Poynard, T., Charlotte, F., Cacoub, P., & Caillat‐Zucman, S. (2006) · Hepatology · doi:10.1002/hep.21438 · Cited by 117
Immunopathogenesis of hepatitis C virus infection
Chang, K. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00068-5 · Cited by 117
Echchakir, H., Mami‐Chouaib, F., Vergnon, I., Baurain, J., Karanikas, V., Chouaı̈b, S., & Coulie, P. G. (2001) · PubMed · Cited by 117
Rothenfußer, S., Hornung, V., Ayyoub, M., Britsch, S., Towarowski, A., Krug, A., Sarris, A., Lübenow, N., Speiser, D. E., Endres, S., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1091 · Cited by 116
Kasmar, A. G., Rhijn, I. V., Cheng, T., Turner, M. T., Seshadri, C., Schiefner, A., Kalathur, R., Annand, J. W., de Jong, A., Shires, J., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110665 · Cited by 116
“Tetramers take advantage of multimer ization to generate high avidity fluorescent staining reagents that bind to individual clonotypic TCRs and selectively track antigenspecific T cells within much larger T cell populations (Altman et al., 1996).”
BackgroundMethodSelf-citationOptogenetic control shows that kinetic proofreading regulates the activity of the T cell receptor
Yousefi, O. S., Günther, M., Hörner, M., Chalupsky, J., Wess, M., Brandl, S. M., Smith, R. W., Fleck, C. C., Kunkel, T., Zurbriggen, M. D., et al. (2019) · eLife · doi:10.7554/elife.42475 · Cited by 116
“, 2007), tetrameric pMHC based on streptavidin are routinely used to stimulate the TCR (Altman et al., 1996) and to obtain insight into ligand discrimination by T cells (Stone et al.”
BackgroundLeavey, J. K., Vance, R. E., Pohl, J., Martin, A. M., Raulet, D. H., & Jensen, P. E. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.613 · Cited by 116
“Soluble Qa-1 b and human b 2-microglobulin ( b 2m) were purified and refolded with peptide as described (38).”
MethodT cell immunity in lymphoid and non-lymphoid tissues
Lefrançois, L., & Masopust, D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00360-6 · Cited by 116
Badovinac, V. P., Hamilton, S. E., & Harty, J. T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00079-7 · Cited by 113
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57
Gillespie, G. M. A., Kaul, R., Dong, T., Yang, H., Rostron, T., Bwayo, J. J., Kiama, P., Peto, T., Plummer, F. A., McMichael, A. J., et al. (2002) · AIDS · doi:10.1097/00002030-200205030-00002 · Cited by 115
“The expression of MHC class I heavy chain, â2-microglobulin, the refolding of B 5701/B 5703 and the biotinylation and tetramerization of complexes were carried out according to previously described protocols [30,31].”
MethodSelf-citationPeperzak, V., Xiao, Y., Veraar, E. A. M., & Borst, J. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40178 · Cited by 120
Human circulating and tissue-resident memory CD8+ T cells
Buggert, M., Price, D. A., Mackay, L. K., & Betts, M. R. (2023) · Nature Immunology · doi:10.1038/s41590-023-01538-6 · Cited by 125
Trollmo, C., Meyer, A. L., Steere, A. C., Hafler, D. A., & Huber, B. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5286 · Cited by 115
Wallen, H. D., Thompson, J. A., Reilly, J. Z., Rodmyre, R. M., Cao, J., & Yee, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004749 · Cited by 115
The Shape of the Lymphocyte Receptor Repertoire: Lessons from the B Cell Receptor
Jackson, K., Kidd, M. J., Wang, Y., & Collins, A. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00263 · Cited by 114
“The development of techniques for the creation of MHC peptide tetramer complexes has facilitated the identification of antigen-specific T cells by flow cytometry (102).”
MethodOuyang, Q., Wagner, W. M., Walter, S., Müller, C. A., Wikby, A., Aubert, G., Klatt, T., Stevanović, S., Dodi, T., & Pawelec, G. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00026-5 · Cited by 113
Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
Schuurhuis, D. H., van Montfoort, N., Ioan‐Facsinay, A., Jiawan-Lalai, R., Camps, M. G. M., Nouta, J., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4573 · Cited by 118
Lin, H., Stacey, M. A., Saxby, C., Knott, V., Chaudhry, Y., Evans, D. J., Gordon, S., McKnight, A. J., Handford, P. A., & Lea, S. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101770200 · Cited by 115
Nepom, G. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102398 · Cited by 118
Shen, H., Whitmire, J. K., Fan, X., Shedlock, D. J., Kaech, S. M., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1443 · Cited by 114
“MHC class I (H-2K) tetramers complexed with LCMV-gp34–41 peptides were produced and used as previously described (61, 62).”
MethodGoulder, P., Brander, C., Annamalai, K., Mngqundaniso, N., Govender, U., Tang, Y., He, S., Hartman, K. E., O’Callaghan, C. A., Ogg, G. S., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5679-5690.2000 · Cited by 114
Self-citationSelective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants
Haanen, J. B. A. G., Wolkers, M. C., Kruisbeek, A. M., & Schumacher, T. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1319 · Cited by 113
“To directly visualize T cells displaying antigen receptors that are monospecific for a certain viral variant or that cross-react between different variants, we used differentially labeled oligomeric peptide–MHC class I complexes (19).”
MethodStatus of Activation of Circulating Vaccine-Elicited CD8+ T Cells
Nielsen, M.-B., Monsurrò, V., Migueles, S. A., Wang, E., Pérez‐Díez, A., Lee, K.-H., Kammula, U. S., Rosenberg, S. A., & Marincola, F. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2287 · Cited by 113
“Tetrameric peptide-HLA-A*0201 complexes were produced as described previously (8, 18).”
MethodNatural killer T cells in health and disease
Kaer, L. V. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s148 · Cited by 113
Depletion of CD4+ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques
Ortiz, A. M., Klatt, N. R., Li, B., Yi, Y., Tabb, B., Hao, X., Sternberg, L., Lawson, B., Carnathan, P. M., Cramer, E. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46023 · Cited by 112
Johnson, A. J., Njenga, M. K., Hansen, M. J., Kuhns, S. T., Chen, L., Rodriguez, M., & Pease, L. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3702-3708.1999 · Cited by 112
“have described a method by which four class I heterodimers bound with a specific peptide can be assembled with fluorescent, conjugated streptavidin and used to stain T cells with T-cell receptors (TCRs) that have affinity for the peptide presented in the context of the class I molecule (1).”
MethodParasite Stage–Specific Recognition of Endogenous Toxoplasma gondii –Derived CD8 + T Cell Epitopes
Frickel, E., Sahoo, N., Hopp, J., Gubbels, M., Craver, M. P. J., Knoll, L. J., Ploegh, H. L., & Grotenbreg, G. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/593019 · Cited by 112
“MHC tetramers enable the direct visualization of antigen-specific T cells [26], and arrays of MHC tetramers can be produced rapidly by using caged MHC complexes.”
Varga, S. M., Wissinger, E., & Braciale, T. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6487 · Cited by 112
“The study of virus-specific T cell populations has been greatly aided by recent technological advances, including the development of tetrameric complexes of MHC glycoprotein loaded with peptides and the staining for intracellular cytokines in cells stimulated with peptides (34, 35), both of which have allowed the dire…”
BackgroundIs immunosenescence influenced by our lifetime “dose” of exercise?
Turner, J. E. (2016) · Biogerontology · doi:10.1007/s10522-016-9642-z · Cited by 112
Gratama, J. W., Boeckh, M., Nakamura, R., Cornelissen, J. J., Brooimans, R. A., Zaia, J. A., Forman, S. J., Gaal, K. K., Bray, K. R., Gasior, G. H., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273508 · Cited by 111
Duration of Antigen Availability Influences the Expansion and Memory Differentiation of T Cells
Blair, D. A., Turner, D., Bose, T. O., Pham, Q.-M., Bouchard, K. R., Williams, K., McAleer, J. P., Cauley, L. S., Vella, A. T., & Lefrançois, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100363 · Cited by 111
“H-2K tetramers containing the OVA-derived peptide SIINFEKL or the vesicular stomatitis virus (VSV) nucleoprotein-derived peptide RGYVYQGL were produced as previously described (28, 29).”
Abbas, A. K., & Janeway, C. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81689-x · Cited by 110
Karanikas, V., Lurquin, C., Colau, D., van Baren, N., Smet, C. D., Lethé, B., Connerotte, T., Corbière, V., Demoitié, M., Líénard, D., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4898 · Cited by 111
“A1), or VSDGGPNLY (influenza basic polymerase 1 (18)), as described previously (19).”
BackgroundRessing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034960100 · Cited by 111
Nakahara, S., Tsunoda, T., Baba, T., Asabe, S., & Tahara, H. (2003) · PubMed · Cited by 112
Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice
Horuzsko, A., Lenfant, F., Munn, D. H., & Mellor, A. L. (2001) · International Immunology · doi:10.1093/intimm/13.3.385 · Cited by 111
“HLA-G tetramer was generated as previously described ( 20 ).”
MethodT lymphocyte responses in HIV-1 infection: implications for vaccine development
Brander, C., & Walker, B. D. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80076-4 · Cited by 111
Takata, H., Buranapraditkun, S., Kessing, C. F., Fletcher, J. L. K., Muir, R., Tardif, V., Cartwright, P., Vandergeeten, C., Bakeman, W., Nichols, C. N., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1809 · Cited by 107
Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to Melanoma
Shen, X. Z., Li, P., Weiss, D., Fuchs, S., Xiao, H., Adams, J. A., Williams, I. R., Capecchi, M. R., Taylor, W. R., & Bernstein, K. E. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061205 · Cited by 110
Kiecker, F., Streitz, M., Aÿ, B., Черепнев, Г. В., Volk, H., Volkmer, R., & Kern, F. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.02.017 · Cited by 110
HIV–1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?
Arnaout, R., Nowak, M. A., & Wodarz, D. (2000) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1149 · Cited by 110
“Using tetramer staining ( Altman et al.1996 ), another study (Ogg et al. 1999) found that the CTL population expressing the activation marker CD38 (Lund et al.1998) decayed with a half-life that ranged from 15 to 60 days, depending on the patient, sometimes preceded by a marked early £uctuation (which the authors theo…”
MethodRezvani, K., Brenchley, J. M., Price, D. A., Kilical, Y., Emma Gostick, D., Sewell, A. K., Li, J., Mielke, S., Douek, D. C., & Barrett, A. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1314 · Cited by 110
Hernández, J., Lee, P. P., Davis, M. M., & Sherman, L. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.596 · Cited by 110
“Production of MHC/peptide tetramers was described in detail elsewhere (28).”
BackgroundSelf-citationSmith, J. W., Walker, E., Fox, B. A., Haley, D. P., Wisner, K. P., Doran, T., Fisher, B. K., Justice, L., Wood, W. A., Vetto, J. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.020 · Cited by 110
Rahimian, S., Fransen, M. F., Kleinovink, J. W., Christensen, J. R., Amidi, M., Hennink, W. E., & OSSENDORP, F. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.006 · Cited by 111
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Koutsakos, M., Reynaldi, A., Lee, W. S., Nguyen, J. T., Amarasena, T. H., Taiaroa, G., Kinsella, P. M., Liew, K. C., Tran, T., Kent, H. E., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.02.017 · Cited by 112
“The use of fluorescently conjugated peptide-MHC (pMHC) multimers can allow for the sensitive detection of antigen-specific T cells and their ex vivo phenotypic characterization in cohorts with known HLA alleles.(28) Indeed, the analyses of antigen-specific CD4 and CD8 T cells using pMHC multimers have provided novel i…”
BackgroundClave, E., Agbalika, F., Bajzik, V., de Latour, R. P., Trillard, M., Rabian, C., Scieux, C., Devergié, A., Socié, G., Ribaud, P., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000093997.83754.2b · Cited by 109
Differential Evolution and Stability of Epitope-Specific CD8+ T Cell Responses in EBV Infection
Catalina, M. D., Sullivan, J. L., Bak, K. R., & Luzuriaga, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4450 · Cited by 109
“The resulting biotinylated monomer was mixed with streptavidinAPC conjugate (BD PharMingen) at a molar ratio of 4:1 to form tetramers (15).”
MethodAgrawal, S. G., Marquet, J., Freeman, G. J., Tawab, A., Bouteiller, P. P. L., Roth, P. A., Bolton, W. E., Ogg, G. S., Boumsell, L., & Bensussan, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1223 · Cited by 109
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection
Klenerman, P., Phillips, R. E., Rinaldo, C. R., Wahl, L. M., Ogg, G. S., May, R. M., McMichael, A. J., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15323 · Cited by 109
Self-citationGoyal, A., Bauer, J., Hey, J., Papageorgiou, D. N., Stepanova, E., Daskalakis, M., Scheid, J., Dubbelaar, M., Klimovich, B., Schwarz, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42417-w · Cited by 102
Dendritic cell vaccination and immune monitoring
Aarntzen, E. H. J. G., Figdor, C. G., Adema, G. J., Punt, C. J. A., & de Vries, I. J. M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0553-y · Cited by 107
“unpulsed DC, (2) ELIspot-assays [31, 55] and (3) tetramer assays [2, 22, 30].”
Bukczynski, J., Wen, T., Ellefsen, K., Gauldie, J., & Watts, T. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306567101 · Cited by 108
Hogan, R. J., Cauley, L. S., Ely, K. H., Cookenham, T. S., Roberts, A. D., Brennan, J. W., Monard, S. P., & Woodland, D. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4976 · Cited by 108
Koelle, D. M., Liu, Z., McClurkan, C. M., Topp, M. S., Riddell, S. R., Pamer, E. G., Johnson, A. S., Wald, A., & Corey, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215537 · Cited by 108
Yang, J., Lemas, V. M., Flinn, I. W., Krone, C., & Ambinder, R. F. (2000) · Blood · doi:10.1182/blood.v95.1.241 · Cited by 108
Role of CD8β Domains in CD8 Coreceptor Function
Bosselut, R., Kubo, S., Guinter, T. I., Kopacz, J., Altman, J. D., Feigenbaum, L., & Singer, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80193-4 · Cited by 108
Self-citationEmergence of CD8+ T Cells Expressing NK Cell Receptors in Influenza A Virus-Infected Mice
Kambayashi, T., Assarsson, E., Michaëlsson, J., Berglund, P., Diehl, A. D., Chambers, B. J., & Ljunggren, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4964 · Cited by 108
Belz, G. T., Altman, J. D., & Doherty, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13812 · Cited by 108
Self-citationFukada, K., Sobao, Y., Tomiyama, H., Oka, S., & Takiguchi, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2225 · Cited by 107
Current status of gene therapy strategies to treat HIV/AIDS
Strayer, D. S., Akkina, R., Bunnell, B. A., Dropulić, B., Planelles, V., Pomerantz, R. J., Rossi, J. J., & Zaia, J. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.020 · Cited by 106
Metadata
- Authors
- Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M.
- Affiliations
- Stanford Medicine (US)
- John Radcliffe Hospital (GB)
- J. D. Altman and M. G. McHeyzer-Williams, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5428, USA.
- Howard Hughes Medical Institute (US)
- Corresponding author
- Davis, Mark M.
- ORCID
- Venue
- Science
- Published
- 1996-10-04
- Volume
- 274
- Issue
- 5284
- Pages
- 94-96
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2067069532
- Cited by
- 3,544
- References
- 39
- Citations by year
- 2026: 44 · 2025: 41 · 2024: 45 · 2023: 59 · 2022: 43 · 2021: 68 · 2020: 59 · 2019: 71 · 2018: 70 · 2017: 42 · 2016: 62 · 2015: 73 · 2014: 69 · 2013: 101 · 2012: 93
- FWCI
- 35.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- antigen-specific T cells, peptide-MHC tetramers, HLA-A2, cytotoxic T lymphocytes, cytotoxicity assay, T cell phenotyping, HIV infection, tumor-specific T cells, autoantigen-specific T cells
- MeSH terms
- Amino Acid Sequence, Epitopes, Antigens, Viral, Base Sequence, Cell Line, Coloring Agents, Flow Cytometry, HIV Seropositivity, Humans, Molecular Sequence Data, Peptide Fragments, Phenotype, RNA-Directed DNA Polymerase, T-Lymphocytes, Cytotoxic, Viral Matrix Proteins, Gene Products, gag, HLA-A2 Antigen, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review